Development challenges associated with rAAV-based gene therapies
Michael W. Bolt, Joseph T. Brady, Lawrence O. Whiteley, K. Nasir Khan
J. Toxicol. Sci., Vol.46, No.2, 57-68, 2021
Development challenges associated with rAAV-based gene therapies
Michael W. Bolt, Joseph T. Brady, Lawrence O. Whiteley, K. Nasir Khan
J. Toxicol. Sci., Vol.46, No.2, 57-68, 2021
Silencing TRPV4 partially reverses the neurotoxic effects caused by excess Ketamine
Chunsong Yang, Mengqing Si, Jing Zhou
J. Toxicol. Sci., Vol.46, No.2, 69-81, 2021
Maky Ideta-Otsuka, Misato Miyai, Naoki Yamamoto, Ayaka Tsuchimoto, Hideki Tamura, Kentaro Tanemura, Makoto Shibutani, Katsuhide Igarashi
J. Toxicol. Sci., Vol.46, No.2, 83-90, 2021
Natsumi Seki, Masahiro Akiyama, Hiroto Yamakawa, Koji Hase, Yoshito Kumagai, Yun-Gi Kim
J. Toxicol. Sci., Vol.46, No.2, 91-97, 2021
Title: The Journal of Toxicological Sciences
Abbreviation: J. Toxicol. Sci.
Publisher: The Japanese Society of Toxicology
Editor-in-Chief: Toshiyuki Kaji
Frequency of Publication: monthly
Editorial Office:
Faculty of Pharmaceutical Sciences
Tokyo University of Science
2641 Yamazaki, Noda 278-8510 JAPAN
E-mail: jts-ed@jtoxsci.org